Skip to main content

Alinia Clinical Prior Authorization Criteria Revision Effective November 23, 2021

Last updated on

The Texas Health and Human Services Commission (HHSC) will revise the Alinia (nitazoxanide) clinical prior authorization criteria on November 23, 2021.

The changes correspond to the current list of drugs requiring prior authorization in the clinical criteria. The drug generic code numbers (GCNs) for the Alinia suspension and tablet brand-name drugs will be removed and replaced with the GCNs for the generic nitazoxanide tablets on the Medicaid formulary. Additionally, HHSC will remove the criteria for Alinia and rename the document “Nitazoxanide.”

The nitazoxanide clinical prior authorization is optional for managed care.

The Pharmacy Clinical Prior Authorization Assistance Chart indicates which prior authorization each managed care organization (MCO) uses. The chart is updated quarterly. Providers can also refer to the MCO Resources page for links to each MCO's list of clinical prior authorizations.

Send questions or comments to vdp-formulary@hhsc.state.tx.us.